Cardiology
Clinical Inquiries
Does taking BP medicine at night (vs morning) result in fewer cardiovascular events?
EVIDENCE-BASED ANSWER: Probably not. In patients who have hypertension, the timing of administration of antihypertensive medications does not...
Conference Coverage
Impressive bleeding profile with factor XI inhibitor in AFib: AZALEA
“This gives us real hope that we have finally found an anticoagulant that is remarkably safe,” said Dr. Christian Ruff.
From the Journals
Atrial fibrillation linked to dementia, especially when diagnosed before age 65 years
Investigators note the findings highlight the importance of monitoring cognitive function in adults with AFib.
Conference Coverage
Blood pressure lowering reduces dementia risk
“This proven, effective intervention should be widely scaled up to reduce the global burden of dementia.”
Conference Coverage
Semaglutide ‘a new pathway’ to CVD risk reduction: SELECT
The SELECT trial was “a turning point in the treatment of obesity and a call to action.”
Sponsored Supplement
Clinical Utility of Low-Density Lipoprotein Particles and Apolipoprotein B in Patients with Cardiovascular Risk
Clinical Inquiries
Does vaginal estrogen use increase the risk for adverse cardiovascular outcomes?
EVIDENCE-BASED ANSWER: NO. In general, nonoral estrogen use for menopausal symptoms is associated with a lower cardiovascular (CV) risk profile...
From the Journals
Two biomarkers promising for preeclampsia prediction
“A more accurate prediction of preeclampsia is expected to improve risk stratification and clinical care and shape clinical practice guidelines,”...
From the Journals
Standing BP measures improve hypertension diagnosis
“Standing office BP has acceptable discriminative capabilities in identifying the presence of hypertension in adults.”
Commentary
Hypertensive disorders of pregnancy and high stroke risk in Black women
These complications of pregnancy serve as a window into a woman’s future cardiometabolic health and a marker of her cardiovascular risk.
Conference Coverage
Aprocitentan reduces resistant hypertension in CKD
Aprocitentan, a novel dual endothelin antagonist, showed antihypertensive efficacy and manageable safety in people with chronic kidney disease.
Conference Coverage
Marijuana use dramatically increases risk of heart problems, stroke
The latest research indicates that smoking and inhaling cannabis increases concentrations of blood carboxyhemoglobin and tar, similar to the...